SCHEMBL19004872

SCHEMBL19004872

C=N/C=C(C)\C=C(/C)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DEGS1 O15121 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ KDM1A O60341 1/20 0.37
▸ MEN1 O00255 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CES2 O00748 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ NR4A1 P22736 1/20 0.33
▸ NR4A2 P43354 1/20 0.33
▸ NR4A3 Q92570 1/20 0.33
▸ MAPK1 P28482 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ AKT1 P31749 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21242007 0.84 KDM1A (0.41) DEGS1SMN1; SMN2KDM1ALMNACES2
SCHEMBL18570750 0.77 DEGS1 (0.44) DEGS1SMN1; SMN2KDM1AMEN1LMNA
SCHEMBL20402442 0.74 KDM4E (0.46) SMN1; SMN2MEN1LMNAKMT2ACES2
SCHEMBL22252510 0.73 DEGS1 (0.44) DEGS1SMN1; SMN2KDM1AMEN1LMNA
SCHEMBL23458135 0.72 ALDH1A1 (0.55) DEGS1SMN1; SMN2LMNAHTTCYP1A2
SCHEMBL9628900 0.72 ALDH1A1 (0.55) DEGS1SMN1; SMN2LMNAHTTCYP1A2
SCHEMBL10479698 0.71 DEGS1 (0.43) DEGS1SMN1; SMN2KDM1AMEN1LMNA
SCHEMBL10479693 0.71 DEGS1 (0.43) DEGS1SMN1; SMN2KDM1AMEN1LMNA
SCHEMBL19141920 0.71 DEGS1 (0.43) DEGS1SMN1; SMN2KDM1AMEN1LMNA
SCHEMBL14851432 0.71 DEGS1 (0.40) DEGS1SMN1; SMN2KDM1AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210198297-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2021-07-01 — — US disclosed
US-20170179404-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170179404-A1 ORGANIC LIGHT-EMITTING DEVICE OR51E2, OCIAD1, OXA1L DEGS1 2676/4885SMN1; SMN2 4082/4885KDM1A 627/4885
US-20210198297-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND L1CAM, MSL1, TLL1 DEGS1 3383/4885SMN1; SMN2 2046/4885KDM1A 1411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback